12:00 AM
Sep 22, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

EDP-322: Phase Ia started

Enanta began a double-blind, placebo-controlled, single ascending-dose, U.S. Phase Ia trial of oral EDP-322 in about...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >